As of January 22, 2025, Akero Therapeutics (AKRO) has a market cap of $1.75 billion USD. According to our data, Akero Therapeutics is ranked No.4352 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.75 B |
-10.06%
|
Dec 31, 2024 | $1.94 B |
19.14%
|
Dec 29, 2023 | $1.63 B |
-57.39%
|
Dec 30, 2022 | $3.82 B |
159.10%
|
Dec 31, 2021 | $1.48 B |
-18.02%
|
Dec 31, 2020 | $1.80 B |
16.24%
|
Dec 31, 2019 | $1.55 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Madrigal Pharmaceuticals
MDGL
|
$7.08 B |
-0.000 M
|
USA
|
Viking Therapeutics
VKTX
|
$3.79 B |
-0.000 M
|
USA
|
Galmed Pharmaceuticals
GLMD
|
$4.72 M |
0.000 M
|
Israel
|
Seabridge Gold
SA
|
$1.12 B |
0.000 M
|
Canada
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Enanta Pharmaceuticals
ENTA
|
$0.11 B |
0.000 M
|
USA
|
89bio
ETNB
|
$0.79 B |
0.000 M
|
USA
|
Arbutus Biopharma
ABUS
|
$0.61 B |
-0.000 M
|
USA
|
Market Cap | = | AKRO Stock Price | * | AKRO Shares Outstanding |
= | $25.02 | * | 69.80 M | |
= | $1.75 B |